The CEO of Sareum Holdings plc, a clinical-stage biotechnology company developing next-generation kinase inhibitors for autoimmune disease and cancer, has stepped aside. After 20 years with the company, co-founder Dr Tim Mitchell will transition to the part-time role of COO. He will continue to serve on Sareum’s board of directors. Dr Stephen Parker, currently non-executive … Continue reading CEO steps aside at listed MedTech Sareum